(Q74222591)
Statements
Prospective sequential trials of induction weekly cisplatin followed by monthly cisplatin, doxorubicin, cyclophosphamide and paclitaxel and cisplatin in optimal (< or = 1 cm) stage III and IV ovarian cancer (English)
Piver MS
Eltabbakh GH
Hempling RE
Recio FO